OmniSonics Medical Technologies is a U.S.-based company that develops medical devices used in the treatment of vascular occlusive diseases.
OmniSonics Medical Technologies is a U.S.-based company that develops medical devices used in the treatment of vascular occlusive diseases. Its products are designed to deliver transverse, ultrasonic energy along the length of a small diameter wire to an artery or vein that has been obstructed by thrombus.OmniSonics Medical Technologies uses low power ultrasonic energy to create cavitational streaming that rapidly dissolves thrombus and quickly restores blood flow without adversely damaging surrounding vessel walls. Its current commercial product, the OmniWave Endovascular System is indicated to infuse physician-specified fluids and remove thrombus in the peripheral vasculature.The company is headquartered in Lakewood, New York.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 10, 2003 | Series C | $43M | 2 | Nomura International | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Nomura International | Yes | Series C |
New England Partners | — | Series C |